- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02862405
Perception of Objects and Natural Scenes in People With Vision Loss (ACTIVIS) (ACTIVIS)
August 8, 2016 updated by: Lille Catholic University
Evaluation of the Perception of Objects and Natural Scenes in People With Vision Loss (Loss of Central or Peripheral Vision)
The loss of central vision causes difficulty not only in reading but also in faces recognition, and in particular in the identification of facial expression, objects or spaces.
These visual deficits have been mainly studied in relation with reading, which is the main complaint of these kind of patients.
However, there are not enough data regarding perception of objects and spaces in this population.
Then, the objectives are to study the visual-spatial abilities in individuals with vision loss, and altered cognitive processes, (2) to develop clinics tools for early detection and quantification of visual-spatial deficits and (3)to understand the capacities of normal peripheral vision in order to test the possibility of potential training for use of peripheral vision when central vision is impaired by an ophthalmic pathology.
Study Overview
Study Type
Observational
Enrollment (Actual)
260
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with eye disease causing loss of central or peripheral vision
Description
Inclusion Criteria cases:
- Patients with eye disease causing loss of central or peripheral vision
- French speakers
- Age between 18 and 90 years old
- Written consent
- Health insurance
Inclusion Criteria controls:
- Sex and age matched controls (+/- 5 years)
- French speakers
- Normal visual examination with visual acuity of min 9/10
Exclusion Criteria:
- Psychiatric disease or neurological pathologies
- Communication difficulties (deafness / mutism)
- Drug treatment altering concentration
- Mental deterioration with MMS <24
- Alcoholism or addiction to drugs
- Persons under guardianship
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients with loss of central vision
Patients coming in ophthalmic consultation will be selected for the study.
The diagnosis of this disease is based on clinical examination, and imaging of the retina.Patients with only loss of central vision will be selected.
|
|
|
Patients with loss of peripheral vision
Patients coming in ophthalmic consultation will be selected for the study.
Patients with loss of peripheral vision will be selected on the bases of presence of tunnel vision.
|
|
|
Control group
Patients without loss of vision.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of performances in visual tests between different groups according to error rate
Time Frame: at inclusion
|
These behavioral studies include a series of short tests of 5 to 10 minutes each (not exceeding 60 minutes with breaks and instructions) in which photos of scenes or isolated objects will be presented in central or peripheral vision using a computer screen or a panoramic screen covering a 180° field.
|
at inclusion
|
|
Comparison of performances in visual tests between different groups according to answer time
Time Frame: at inclusion
|
These behavioral studies include a series of short tests of 5 to 10 minutes each (not exceeding 60 minutes with breaks and instructions) in which photos of scenes or isolated objects will be presented in central or peripheral vision using a computer screen or a panoramic screen covering a 180° field.
|
at inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Estimation of the score of visual acuity by the logMAR chart
Time Frame: at inclusion
|
at inclusion
|
|
|
Measure of lesion size
Time Frame: at inclusion
|
at inclusion
|
|
|
Pearson correlation coefficient to determine the correlation between the performance parameters during visual tests (error rate and answer time) and clinical parameters (visual acuity and lesion size)
Time Frame: at inclusion
|
These behavioral studies include a series of short tests of 5 to 10 minutes each (not exceeding 60 minutes with breaks and instructions) in which photos of scenes or isolated objects will be presented in central or peripheral vision using a computer screen or a panoramic screen covering a 180° field.
|
at inclusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Thi Ha Chau Tran, MD, Hospital of the Lille Catholic Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Actual)
March 1, 2015
Study Completion (Actual)
March 1, 2015
Study Registration Dates
First Submitted
August 2, 2016
First Submitted That Met QC Criteria
August 8, 2016
First Posted (Estimate)
August 11, 2016
Study Record Updates
Last Update Posted (Estimate)
August 11, 2016
Last Update Submitted That Met QC Criteria
August 8, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC-P009
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vision Loss
-
Ocuphire Pharma, Inc.Ophthalmic Consultants of Long IslandCompletedDecrease in Night Vision | Disturbance; Vision, LossUnited States
-
London Health Sciences Centre Research Institute...Not yet recruitingIrreversible Vision Loss
-
University Hospital Hradec KraloveNot yet recruiting
-
Sun Yat-sen UniversityRecruiting
-
Ocuphire Pharma, Inc.CompletedNight Vision Complaints | Decrease in Night Vision | Disturbance; Vision, LossUnited States
-
University of NottinghamNottingham University Hospitals NHS Trust; The Dunhill Medical TrustActive, not recruitingFalls | Vision; Disorder, LossUnited Kingdom
-
National Eye Institute (NEI)Active, not recruitingCentral Vision Loss From Macular DiseasesUnited States
-
University of NebraskaCompleted
-
VA Office of Research and DevelopmentCompletedCentral Vision Loss From Macular DiseasesUnited States
-
Direction Centrale du Service de Santé des ArméesCompleted
Clinical Trials on vision tests
-
Centre Hospitalier National d'Ophtalmologie des...Recruiting
-
Tilak HealthcareCompleted
-
Essilor InternationalCompletedPresbyopia | Near Vision | Refraction ErrorFrance
-
Assiut UniversityNot yet recruitingMultiple Sclerosis
-
Fondation Ophtalmologique Adolphe de RothschildRecruiting
-
Fondation Ophtalmologique Adolphe de RothschildTerminatedHereditary Retinal DystrophiesFrance
-
VA Office of Research and DevelopmentCompletedCentral Vision Loss From Macular DiseasesUnited States
-
Hospices Civils de LyonFondation pour la Recherche MédicaleCompletedChronic Optic Neuropathy in Multiple SclerosisFrance
-
Nunaps IncCompletedVisual Fields Hemianopsia | Hemianopsia, HomonymousKorea, Republic of